Very High-Risk Prostate Cancer Survival Tied to Radiation Facility Volume
Whether the center was an academic setting or not had no bearing on results.
Diagnosis & Disease Information
Adding Olaparib to Abiraterone Does Not Worsen HRQoL in mCRPC
This HRQoL analysis can help inform discussions of the benefit-risk profile of olaparib plus abiraterone.
For Prostate Cancer Info Videos, Patients Prefer Hearing From a Physician
And, racial concordance between patient and physician important for trust among Black adults.
Toxicity Reduced With MRI-Guided Radiotherapy for Prostate Cancer
Odds ratios for acute grade 2 or higher genitourinary and gastrointestinal toxicities reduced for MRg-A-SBRT versus CT-SBRT.
Novel Radiotracer Targeting PSMA Shows Promise for Prostate Cancer Detection
According to investigators, the totality of the data support the potential clinical utility of 18F-rhPSMA-7.3.
Docetaxel “Best Suited” for Poor-Prognosis Metastatic Hormone-Sensitive Prostate Cancer
Adding docetaxel to ADT is most beneficial for patients with mHSPC who have poor prognosis, according to researchers.
Indigenous Men Less Likely to Receive PSA Testing
Indigenous men with prostate cancer are also more likely to have higher-risk disease characteristics.
Social Vulnerability Affects Cancer-Related Mortality Rates in the US
Researchers sought to determine the age-adjusted mortality rates related to cancer in US counties.
Niraparib Improves rPFS in Patients With mCRPC and HRR Alterations
Adding niraparib to first-line treatment with AAP can improve outcomes in patients with mCRPC and HRR alterations, a phase 3 trial suggests.
Artificial Intelligence Has Great Potential in Oncology Nursing, More Research Needed
Researchers sought to determine whether AI could improve oncology nursing for patients with cancer.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...